Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 7;9:657219. doi: 10.3389/fcell.2021.657219

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Yang, Wu, Mou, Zhou, Zhang, Chen, Ou, Chen, Dai, Xu, Liu and Jiang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Knockdown of ARHGAP5-, ARHGAP17-, and ARHGAP24-suppressed BC cell proliferation in vivo and in vitro. (A) System analysis of expression of ARHGAP family gene in BCa cancer cell lines in the CCLE database. (B) ARHGAP5, ARHGAP17, and ARHGAP24 expression in seven pairs of low-grade BCa and seven pairs of high-grade BCa; GAPDH serves as a loading control. (C) ARHGAP5, ARHGAP17, and ARHGAP24 expression in four bladder transitional cell carcinoma cell lines (RT4, UM-UC-3, T24, and 5637) compared with immortalized epithelium cell line (SV-HUC-1). (D,E) Cloning formation of T24, UMUC-3, and ARHGAP5, ARHGAP17, and ARHGAP24 knocking down T24, UMUC-3 (***p < 0.001 versus shNC). (F,G) 5-Ethynyl-2′-deoxyuridine (EdU) assay of T24 and shARHGAP5-, ARHGAP17-, and ARHGAP24-transfected T24 (***p < 0.001 versus shNC). (H) Tumor growth size of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 21 days after tumor implantation. (I) Tumor growth curve of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 in 21 days of tumor implantation. (J) Average weights of tumors from shNC and shARHGAP5, ARHGAP17, and ARHGAP24 are shown in the histogram. Error bars indicate SD.

HHS Vulnerability Disclosure